Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 2;5(1):243-249.
doi: 10.1159/000546242. eCollection 2025 Jan-Dec.

Familial Idiopathic Glomerular Disease due to a Unique Renal-Predominant Phenotype of MYH9-Related Disease: A Case Report

Affiliations

Familial Idiopathic Glomerular Disease due to a Unique Renal-Predominant Phenotype of MYH9-Related Disease: A Case Report

Natasha S Freeman et al. Glomerular Dis. .

Abstract

Introduction: MYH9-related disease (MYH9-RD) is a rare genetic cause of proteinuric kidney disease. It typically manifests as a syndromic condition, presenting with macrocytic thrombocytopenia, sensorineural hearing loss (SNHL), chronic glomerulopathy, elevated liver enzymes, and early-onset bilateral cataracts. In accordance with CARE guidelines, we present a case report of a father and daughter with renal-predominant MYH9-RD due to a recently described missense variant affecting the head domain of non-muscle myosin heavy chain IIA.

Case presentations: Patient 1 was an 18-year-old woman with childhood proteinuria who presented with severely advanced kidney failure. Dialysis was initiated as a bridge to a living unrelated renal transplant (LURT). Family history was notable for proteinuric kidney disease in her father (patient 2). Eight years later, genetic testing identified a likely pathogenic missense variant in the head domain of the MYH9 gene (c.1271G>A, p.R424Q). A predictive structural model was obtained via AlphaFold Protein Structure Database, in which the mutation interrupts hydrogen bonding and π-cation interactions, likely leading to protein misfolding. Subsequent clinical screening revealed persistent mild thrombocytopenia and elevated liver enzymes, without cataracts or SNHL. Patient 2 was a 53-year-old man with childhood proteinuria who eventually presented with stage 4 chronic kidney disease and soon after underwent LURT. After patient 1's genetic diagnosis, he was confirmed to have the same mutation by genetic testing. Subsequent screening revealed mild thrombocytopenia and elevated liver enzymes with hepatic steatosis progressing to cirrhosis, without cataracts or SNHL.

Conclusion: The finding of this MYH9 p.R424Q variant confirmed a diagnosis of MYH9-RD in these patients. MYH9 variants affecting the head domain typically result in severe thrombocytopenia. This recently reported head domain variant caused severe renal manifestations with mild thrombocytopenia and no manifestations of SNHL or cataracts in both patients, suggesting that this variant causes a renal-predominant form of MYH9-RD.

Keywords: Case report; Genetics; Glomerular diseases; MYH9-related disease; Proteinuria.

PubMed Disclaimer

Conflict of interest statement

N.S.F. and K.B. have no conflicts of interest. A.B. received support from NIH-NIDDK [K08DK132511], the Gerstner Family Foundation, and the American Society of Nephrology and Kidney Cure Carl W. Gottschalk Research Scholar Award. J.G.N. received support from the NIH-NIDDK [K08DK132511] and the American Society of Nephrology and Kidney Cure’s Harold Amos Medical Faculty Development Award. S.S.-C. is supported by the Department of Defense grant [W81XWH-22-1-0966] and by the National Institute of Health Grant [RC2-DK122397] and is an Associate Editor of Glomerular Diseases. P.A.C. is on the Editorial Board of Glomerular Diseases. Dr. Simone Sanna-Cherchi and Dr. Pietro A. Canetta were members of the journal’s Editorial Board at the time of submission.

Figures

Fig. 1.
Fig. 1.
The structure of MYH9 surrounding R424 from the AlphaFold Protein Structure Database is depicted in wheat. The side chain of R424 is shown to hydrogen bond with carbonyl groups from neighboring alpha helices, and it also packs against a tryptophan residue to form a π-cation interaction. The glutamine residue of MYH9 p.R424Q is represented in magenta. Its smaller size substantially attenuates the intramolecular hydrogen bonding between helices, and its lack of charge ablates the π-cation interaction.

Similar articles

References

    1. Singh N, Nainani N, Arora P, Venuto RC. CKD in MYH9-related disorders. Am J Kidney Dis. 2009;54(4):732–40. - PubMed
    1. Wong L, Huang LL, Nedeljkovic M, Irish A, McMahon LP. Nephritis and hearing loss-not all roads lead to Alport syndrome. Kidney Int Rep. 2021;6(11):2922–5. - PMC - PubMed
    1. Pecci A, Klersy C, Gresele P, Lee KJD, De Rocco D, Bozzi V, et al. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. Hum Mutat. 2014;35(2):236–47. - PMC - PubMed
    1. Tabibzadeh N, Fleury D, Labatut D, Bridoux F, Lionet A, Jourde-Chiche N, et al. MYH9-related disorders display heterogeneous kidney involvement and outcome. Clin Kidney J. 2019;12(4):494–502. - PMC - PubMed
    1. Groopman EE, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal VS, Milo-Rasouly H, et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med. 2019;380(2):142–51. - PMC - PubMed